Sequenom Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Sequenom Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011949
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sequenom Inc (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical laboratory (MDCL) that specializes in the field of in prenatal health. Sequenom offers wide collection of carrier status, noninvasive prenatal testing, and diagnostic test options ranging from baby’s whole genome assessment to specific conditions identification which allows parents and physicians to select the right test for each pregnancy. The molecular genetic laboratory-developed tests offer early patient management information for geneticists, maternal fetal medicine specialists, and obstetricians as well as patients. Its MDCLs are located at San Diego, California; Raleigh-Durham, North Carolina; and Grand Rapids, Michigan. Sequenom is headquartered in San Diego, California, the US.

Sequenom Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sequenom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sequenom Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Sequenom Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 11
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 13
Partnerships 14
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 14
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 15
Sequenom Enters Into Licensing Agreement With LifeCodexx 16
Sequenom enters into an Agreement with University of California 17
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 18
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 19
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 20
New England Biolabs Enters Into Licensing Agreement With Sequenom 21
Equity Offering 22
Sequenom Completes Public Offering Of Common Stock For US$62 Million 22
Debt Offering 24
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 24
Asset Transactions 26
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 26
Acquisition 27
LabCorp Acquires Sequenom 27
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 29
Sequenom Inc – Key Competitors 30
Sequenom Inc – Key Employees 31
Sequenom Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 34
Strategy And Business Planning 34
Mar 02, 2016: Sequenom Announces Contract with Anthem BlueCross 34
Jan 07, 2016: Sequenom Announces Restructuring: Plans Sale Of North Carolina Operations And Initiatives To Improve Efficiencies 35
Financial Announcements 36
May 04, 2016: Sequenom Reports First Quarter 2016 Results 36
Mar 02, 2016: Sequenom Reports 2015 Financial Results 38
Jan 11, 2016: Sequenom Announces Preliminary 2015 Results 40
Corporate Communications 41
Apr 12, 2016: Sequenom Strengthens Executive Team with New Vice President of Sales 41
Legal and Regulatory 42
Jun 27, 2016: The Supreme Court Of The United States Denies Sequenom’s Petition Requesting Review Of Decision On ’540 Patent 42
Mar 21, 2016: Sequenom Files Petition With the Supreme Court of the United States Requesting Review Of Decision On ’540 Patent 43
Product News 44
02/25/2016: Sequenom Laboratories Announces Positive Results from Clinical Validation Study on the MaterniT GENOME Test 44
01/11/2016: Sequenom Provides Update On MaterniT Genome Test 45
Other Significant Developments 46
May 03, 2016: Sequenom Announces In-Network Contracts with Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin 46
Apr 19, 2016: Sequenom Completes Consolidation of North Carolina Operations 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Sequenom Inc, Medical Equipment, Key Facts 2
Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sequenom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sequenom Inc, Deals By Market, 2011 to YTD 2017 9
Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 11
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 13
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 14
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 15
Sequenom Enters Into Licensing Agreement With LifeCodexx 16
Sequenom enters into an Agreement with University of California 17
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 18
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 19
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 20
New England Biolabs Enters Into Licensing Agreement With Sequenom 21
Sequenom Completes Public Offering Of Common Stock For US$62 Million 22
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 24
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 26
LabCorp Acquires Sequenom 27
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 29
Sequenom Inc, Key Competitors 30
Sequenom Inc, Key Employees 31
Sequenom Inc, Other Locations 32
Sequenom Inc, Subsidiaries 32

★海外企業調査レポート[Sequenom Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sumitomo Heavy Industries Construction Cranes Co., Ltd.
    Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Cheniere Energy Inc (LNG):企業の財務・戦略的SWOT分析
    Cheniere Energy Inc (LNG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Genus Power Infrastructures Ltd (GENUSPOWER):企業の財務・戦略的SWOT分析
    Summary Genus Power Infrastructures Ltd (Genus Power), a subsidiary of Kailash Group, is an electronic equipment manufacturer that develops and distributes electric energy equipment. The company’s products include metering solution products, engineering construction and contracts, solar energy solut …
  • Hikma Pharmaceuticals PLC:企業の戦略・SWOT・財務情報
    Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report Summary Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Intellicheck, Inc. (IDN):企業の財務・戦略的SWOT分析
    Intellicheck, Inc. (IDN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ClearStream Energy Services Inc:企業の戦略・SWOT・財務情報
    ClearStream Energy Services Inc - Strategy, SWOT and Corporate Finance Report Summary ClearStream Energy Services Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Environmental Tectonics Corporation:企業の戦略・SWOT・財務情報
    Environmental Tectonics Corporation - Strategy, SWOT and Corporate Finance Report Summary Environmental Tectonics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • New Zealand Oil & Gas Ltd (NZO):企業の財務・戦略的SWOT分析
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas exploration, development and production company. It acquires, explores, and develops crude oil and natural gas properties. NZOG’s producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampang PSC. The company pa …
  • AxoGen Inc (AXGN):企業の財務・戦略的SWOT分析
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among …
  • Recylex SA:企業の戦略・SWOT・財務情報
    Recylex SA - Strategy, SWOT and Corporate Finance Report Summary Recylex SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Opsona Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Opsona Therapeutics Ltd (Opsona) is a drug developing company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that is …
  • Siemens AG (SIE):企業の財務・戦略的SWOT分析
    Siemens AG (SIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Axpo Holding AG:企業の戦略的SWOT分析
    Axpo Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Affymetrix, Inc.-医療機器分野:企業M&A・提携分析
    Summary Affymetrix, Inc. (Affymetrix) provides life science, and molecular diagnostic products for analysis of biological systems at gene, protein and cellular level. It offers products for two major applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • N Brown Group plc:企業の戦略・SWOT・財務情報
    N Brown Group plc - Strategy, SWOT and Corporate Finance Report Summary N Brown Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bharat Road Network Limited (BRNL):企業の財務・戦略的SWOT分析
    Bharat Road Network Limited (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • GEN energija, d.o.o.:発電所・企業SWOT分析
    GEN energija, d.o.o. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Archer Daniels Midland Co:企業のM&A・事業提携・投資動向
    Archer Daniels Midland Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Archer Daniels Midland Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Allergan Plc (AGN):医療機器:M&Aディール及び事業提携情報
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆